Search - tctmd.com

Displaying 501 - 520 of 675

Sort: Relevancy | Date

Presentation TCT 2017

Small Vessel Stenting Snapshot 2: The Svelte Sirolimus-Eluting Stent

Presenter: Julinda Mehilli, Giulio G. Stefanini, Sunil V. Rao

October 30, 2017

Presentation TCT 2017

The American Vision of Regenerative Cardiovascular Medicine

Presenter: Anthony N. DeMaria, Francisco Fdez-Aviles

October 30, 2017

Presentation TCT 2017

Small Vessel Stenting Snapshot 1: The Onyx 2.0 Zotarolimus-Eluting Stent

Presenter: Julinda Mehilli, Giulio G. Stefanini, Matthew J. Price

October 30, 2017

Presentation TCT 2017

Outcomes With the Stentys Self-Expanding DES in STEMI and Other Clinical Scenarios

Presenter: Julinda Mehilli, Giulio G. Stefanini, Roxana Mehran

October 30, 2017

Presentation TCT 2017

The European Vision of Regenerative Cardiovascular Medicine: The New CARE Working Group of the ESC

Presenter: Anthony N. DeMaria, Francisco Fdez-Aviles, Jens Kastrup

October 30, 2017

Presentation TCT 2017

Case Resolution: STEMI With Multivessel Disease How We Treated

Presenter: Sripal Bangalore, Anthony H. Gershlick, Prashant Kaul

October 30, 2017

Presentation TCT 2017

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Presenter: Julinda Mehilli, Giulio G. Stefanini, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

STEMI/ACS With Multivessel Disease: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Jacqueline E. Tamis-Holland

October 30, 2017

Presentation TCT 2017

Emerging Thromboresistant BMS 2: Titanium-Nitride-Oxide Stents

Presenter: Julinda Mehilli, Giulio G. Stefanini, Pim A.L. Tonino

October 30, 2017

Presentation TCT 2017

Emerging Thromboresistant BMS 1: Cobra PzF Stents

Presenter: Julinda Mehilli, Giulio G. Stefanini, Donald Cutlip

October 30, 2017

Presentation TCT 2017

STEMI/ACS With Multivessel Disease: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Stefan K. James

October 30, 2017

Presentation TCT 2017

Should BMS Stay On the Shelf? Clinical and Global Perspectives on the Role Of BMS in 2017

Presenter: Julinda Mehilli, Giulio G. Stefanini, Raffaele Piccolo

October 30, 2017

Presentation TCT 2017

Case Introduction: STEMI With Multivessel Disease How Should We Treat?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Prashant Kaul

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the Ongoing DES 3-Month DAPT Studies With Synergy and Xience Change How We Treat High Risk Bleeding Patients?

Presenter: C. Michael Gibson, Stephan Windecker

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds?

Presenter: C. Michael Gibson, Stephan Windecker, Stephan Achenbach

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing TWILIGHT and GLOBAL LEADERS Trials Change The Current Recommended Approach to Chronic Antiplatelet Therapy?

Presenter: C. Michael Gibson, Stephan Windecker, Eric R. Bates

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing COMPLETE Trial Change the Current Recommended Approach to Multivessel Disease in STEMI?

Presenter: C. Michael Gibson, Stephan Windecker, David Hildick-Smith

October 30, 2017

News Opinion Off Script TCT 2017

Off Script: Welcome to TCT 2017 in the Mile High City

Kwan S. Lee

October 29, 2017

News Conference News ESC 2017

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Michael O'Riordan

August 28, 2017

News Daily News

CDC Says Only One in Three Post-MI Patients Get Outpatient Cardiac Rehab

L.A. McKeown

August 25, 2017

Advertisement

Small Vessel Stenting Snapshot 2: The Svelte Sirolimus-Eluting Stent

The American Vision of Regenerative Cardiovascular Medicine

Small Vessel Stenting Snapshot 1: The Onyx 2.0 Zotarolimus-Eluting Stent

Outcomes With the Stentys Self-Expanding DES in STEMI and Other Clinical Scenarios

The European Vision of Regenerative Cardiovascular Medicine: The New CARE Working Group of the ESC

Case Resolution: STEMI With Multivessel Disease How We Treated

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

STEMI/ACS With Multivessel Disease: What Do the US Guidelines and AUC Say?

Emerging Thromboresistant BMS 2: Titanium-Nitride-Oxide Stents

Emerging Thromboresistant BMS 1: Cobra PzF Stents

STEMI/ACS With Multivessel Disease: What Do the Data and EU Guidelines Say?

Should BMS Stay On the Shelf? Clinical and Global Perspectives on the Role Of BMS in 2017

Case Introduction: STEMI With Multivessel Disease How Should We Treat?

Predicting The Future: Will the Ongoing DES 3-Month DAPT Studies With Synergy and Xience Change How We Treat High Risk Bleeding Patients?

Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds?

Predicting the Future: Will the Ongoing TWILIGHT and GLOBAL LEADERS Trials Change The Current Recommended Approach to Chronic Antiplatelet Therapy?

Predicting the Future: Will the Ongoing COMPLETE Trial Change the Current Recommended Approach to Multivessel Disease in STEMI?

Off Script: Welcome to TCT 2017 in the Mile High City

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

CDC Says Only One in Three Post-MI Patients Get Outpatient Cardiac Rehab

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content